Streetbeat News

Products Services

GILD

Pantherx Rare is partnering with Gilead Sciences for the distribution of Livdelzi.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 3:38 pm

GILD

Gilead Sciences (NASDAQ:GILD) has filed a new lawsuit against Peter Khaim and two New York City pharmacies for allegedly counterfeiting its HIV medications, Biktarvy and Descovy. The company seized $750,000 worth of fake drugs in July. This is Gilead's second major legal action against Khaim, who had previously been prohibited from selling Gilead-branded products.

Portfolio Pulse from Vandana Singh

August 16, 2024 | 3:24 pm

GOOGL

NVDA

TEM

Tempus AI Inc. (NASDAQ:TEM) has seen a significant rise in its stock price, reaching a new high of $47.81. The stock is up 17.27% since its IPO in June, driven by strategic investments from SoftBank and Google. SoftBank's recent acquisition of 5.41 million shares has particularly boosted investor sentiment. The stock is showing strong bullish signals, with its price well above key moving averages.

Portfolio Pulse from Surbhi Jain

August 16, 2024 | 3:24 pm

CNI

EWC

NSC

SPY

Norfolk Southern has closed intermodal facility ingates to CN Canadian destinations due to potential work stoppages. CN has issued an embargo on all intermodal shipments effective August 16.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 3:13 pm

BYDDY

HMC

BYD Co., Ltd. (OTC:BYDDY) is set to establish an electric vehicle (EV) plant in Pakistan, aiming to expand its global market presence. The company will display three models at its brand launch and plans to introduce battery-electric and plug-in hybrid vehicles. The plant, located near Karachi’s Port Qasim, is expected to be completed by the first half of 2026. BYD has partnered with Mega Conglomerate Pvt. and plans to open showrooms in Karachi, Lahore, and Islamabad, with sales starting in Q4 2023. The news also mentions competition from Toyota (NYSE:TM) and Honda (NYSE:HMC) in Pakistan.

Portfolio Pulse from Nabaparna Bhattacharya

August 16, 2024 | 3:07 pm

RIVN

Rivian Automotive, Inc. (NASDAQ:RIVN) shares are trading lower due to a halt in production of its electric commercial van for Amazon, caused by a parts deficit. The halt began earlier this month at Rivian's Illinois factory. Despite the pause, production of R1 electric pickup and SUV models remains unaffected. Rivian expects to recover all missed production and has accumulated an excess of delivery vans awaiting shipment to Amazon.

Portfolio Pulse from Nabaparna Bhattacharya

August 16, 2024 | 2:59 pm

GDX

GLD

GOLD

NEM

SSRM

UUP

Gold prices hit an all-time high of $2,500 per ounce due to a weakening U.S. dollar and declining Treasury yields. This surge is driven by expectations of Federal Reserve rate cuts. Gold ETFs, including SPDR Gold Trust (GLD), saw strong inflows in July. Gold mining stocks, such as those in the VanEck Gold Miners ETF (GDX), also performed well.

Portfolio Pulse from Piero Cingari

August 16, 2024 | 2:59 pm

CXXIF

C21 Investments Inc. reported a net loss and a slight revenue increase for Q1 2024, with Nevada sales declining by 1%. The company faced inflationary pressures and internal inventory issues but expects improved margins in the second half of the year. The launch of a new dispensary and a recent acquisition are expected to drive future growth.

Portfolio Pulse from Nina Zdinjak

August 16, 2024 | 2:51 pm

BVNKF

BVNRY

Bavarian Nordic has submitted clinical data to the European Medicines Agency to extend the use of its Imvanex vaccine to adolescents aged 12-17. The vaccine, known as Jynneos in the U.S., is currently approved for adults. The submission is based on a study showing similar immune responses and safety profiles in both adolescents and adults. Bavarian Nordic is also planning a trial for children aged 2-12. The company has a stock of ready-to-ship doses and expects to deliver 2 million doses by the end of the year. Bavarian Nordic's stock rose 15.39% to $14.02.

Portfolio Pulse from Vandana Singh

August 16, 2024 | 2:44 pm

BURU

Nuburu has received a Notice of Allowance for its U.S. Patent Application 16/550,216, titled 'Blue Laser Metal Additive Manufacturing System'. This patent is expected to enhance Nuburu's technological capabilities in the metal additive manufacturing sector.

Portfolio Pulse from Benzinga Newsdesk

August 16, 2024 | 2:34 pm